Joshua B. Mcclain

Suzhou Industrial Park
Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III rabies post-exposure population: A randomized, double-blind, positive control, phase III clinical trial.

The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III rabies post-exposure population: A randomized, double-blind, positive control, phase III clinical trial.

Journal: Vaccine

Published: February 24, 2025

A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies.

A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies.

Journal: Vaccine

Published: March 29, 2024

Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial.

Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial.

Journal: Vaccine

Published: May 10, 2021

Safety, Pharmacokinetics, and Neutralizing Activity of SYN023, a Mixture of Two Novel Antirabies Monoclonal Antibodies Intended for Use in Postrabies Exposure Prophylaxis.

Safety, Pharmacokinetics, and Neutralizing Activity of SYN023, a Mixture of Two Novel Antirabies Monoclonal Antibodies Intended for Use in Postrabies Exposure Prophylaxis.

Journal: Clinical pharmacology in drug development

Published: September 17, 2020

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants.

Journal: JCI insight

Published: May 07, 2019

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.

Journal: Tropical medicine & international health : TM & IH

Published: November 16, 2017

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.

Journal: American journal of respiratory and critical care medicine

Published: January 07, 2017

Japanese Immigrant with Abdominal Pain.

Japanese Immigrant with Abdominal Pain.

Journal: The Journal of emergency medicine

Published: September 05, 2016

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.

Journal: The Lancet. Respiratory medicine

Published: September 01, 2016

Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.

Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials.

Journal: Vaccine

Published: July 02, 2016

Purpura and leukopenia in a cocaine user.

Purpura and leukopenia in a cocaine user.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: May 14, 2016

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Journal: Nature communications

Published: May 07, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026